Aspiro Therapeutics to Present at ATS Respiratory Innovation Summit 2026
Tucson, Arizona / April 14, 2026 — Aspiro Therapeutics, a preclinical-stage biopharmaceutical company pioneering the development of groundbreaking, disease-modifying therapies for obstructive lung diseases, today announced that it will present new data at the American Thoracic Society Respiratory Innovation Summit (RIS), taking place May 15 to 16, 2026 in Orlando, Florida. The poster highlights a […]